Francesco Balestrieri is ad interim CEO of Sandoz, effective April 1, 2019.
Mr. Balestrieri joined Novartis in 1993 and has spent the past eight years in leadership roles at Sandoz. Prior to his current position, he was Region Head of Europe from 2018 to 2019; Region Head of Central and Eastern Europe, the Middle East and Africa from 2015 to 2018; Region Head of Central and Eastern Europe from 2013 to 2015; and Region Head of Asia-Pacific from 2011 to 2013. Before that, Mr. Balestrieri held roles including President of the Americas at Ciba Vision, and General Manager of Germany, Austria and Switzerland at Ciba Vision.
Mr. Balestrieri received a Master of Business Administration from the University of Venice in Italy. He is a Board member of Sandoz Italy, Sandoz Spain and Sandoz Nordics. Additionally, he serves on the supervisory board of Lek, a Sandoz company, and on the executive committee of Medicines for Europe.